NCT00487682View on ClinicalTrials.gov

Dose-finding Study of ASP2151 in Subjects With Herpes Zoster

PHASE2CompletedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

November 13, 2007

Primary Completion Date

September 1, 2008

Study Completion Date

September 1, 2008

Conditions
Herpes Zoster
Interventions
DRUG

ASP2151

oral

DRUG

Valacyclovir hydrochloride

oral

Trial Locations (5)

Unknown

Chūbu

Hokkaido

Kanto

Kinki

Kyusyu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY